Safety, effectiveness, and practicality of endovascular therapy within the first 3 hours of acute ischemic stroke onset

Neurosurgery

Volumn 65, Issue 5, 2009, Pages 860-865

  Mathews, Marlon S ^a,b   Sharma, Jitendra ^a,b   Snyder, Kenneth V ^a,b   Natarajan, Sabareesh K ^a,b   Siddiqui, Adnan H ^b   Hopkins, L Nelson ^b   Levy, Elad I ^b  

^a State University   (United States)

^b Millard Fillmore Gates Circle Hospital   (United States)

Author keywords

Acute ischemic stroke; Endovascular therapy; Recanalization; Revascularization

Indexed keywords

EPTIFIBATIDE; FIBRINOLYTIC AGENT; TISSUE PLASMINOGEN ACTIVATOR;

ADOLESCENT; ADULT; AGED; ANGIOGRAPHY; ARTERY DISSECTION; ARTICLE; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; COMORBIDITY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; ENDOVASCULAR SURGERY; FEMALE; FIBRINOLYTIC THERAPY; GUIDE WIRE; HEART LEFT RIGHT SHUNT; HEART SEPTUM DEFECT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANKIN SCALE; RECANALIZATION; RETROSPECTIVE STUDY; REVASCULARIZATION; SAFETY; STENT; STROKE; SUBARACHNOID HEMORRHAGE; THROMBECTOMY; TREATMENT FAILURE; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANGIOPLASTY; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; STENTS; STROKE; THROMBOLYTIC THERAPY; TIME; TISSUE PLASMINOGEN ACTIVATOR; YOUNG ADULT;

EID: 70350291864     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000358953.19069.E5     Document Type: Article

References (33)

1. Albers GW, Bates VE, Clark WM, Bell R, Verro P, Hamilton SA: Intravenous tissue-type plasminogen activator for treatment of acute stroke: The Standard Treatment with Alteplase to Reverse Stroke (STARS) study. JAMA 283:1145-1150, 2000.
2. Asimos AW, Norton HJ, Price MF, Cheek WM: Therapeutic yield and outcomes of a community teaching hospital code stroke protocol. Acad Emerg Med 11:361-370, 2004.
3. Brandt T, von Kummer R, Müller-Küppers M, Hacke W: Thrombolytic therapy of acute basilar artery occlusion. Variables affecting recanalization and outcome. Stroke 27:875-881, 1996.
4. Brekenfeld C, Remonda L, Nedeltchev K, V Bredow F, Ozdoba C, Wiest R, Arnold M, Mattle HP, Schroth G: Endovascular neuroradiological treatment of acute ischemic stroke: Techniques and results in 350 patients. Neurol Res 27 [Suppl 1]:S29-S35, 2005.
5. Brückmann H, Ferbert A, del Zoppo GJ, Hacke W, Zeumer H: Acute vertebral-basilar thrombosis. Angiologic-clinical comparison and therapeutic implications. Acta Radiol Suppl 369:38-42, 1986.
6. Chapman KM, Woolfenden AR, Graeb D, Johnston DC, Beckman J, Schulzer M, Teal PA: Intravenous tissue plasminogen activator for acute ischemic stroke: A Canadian hospital's experience. Stroke 31:2920-2924, 2000.
7. del Zoppo GJ, Higashida RT, Furlan AJ, Pessin MS, Rowley HA, Gent M: PROACT: A phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism. Stroke 29:4-11, 1998.
8. Dick AP, Straka J: IV tPA for acute ischemic stroke: Results of the first 101 patients in a community practice. Neurologist 11:305-308, 2005.
9. Endo S, Kuwayama N, Hirashima Y, Akai T, Nishijima M, Takaku A: Results of urgent thrombolysis in patients with major stroke and atherothrombotic occlusion of the cervical internal carotid artery. AJNR Am J Neuroradiol 19:1169-1175, 1998.
10. Fischer U, Arnold M, Nedeltchev K, Brekenfeld C, Ballinari P, Remonda L, Schroth G, Mattle HP: NIHSS score and arteriographic findings in acute ischemic stroke. Stroke 36:2121-2125, 2005.
11. Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, Pessin M, Ahuja A, Callahan F, Clark WM, Silver F, Rivera F: Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: A randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 282:2003-2011, 1999.
12. Hacke W, Albers G, Al-Rawi Y, Bogousslavsky J, Davalos A, Eliasziw M, Fischer M, Furlan A, Kaste M, Lees KR, Soehngen M, Warach S; DIAS Study Group: The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): A phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 36:66-73, 2005.
13. Hacke W, Donnan G, Fieschi C, Kaste M, von Kummer R, Broderick JP, Brott T, Frankel M, Grotta JC, Haley EC Jr, Kwiatkowski T, Levine SR, Lewandowski C, Lu M, Lyden P, Marler JR, Patel S, Tilley BC, Albers G, Bluhmki E, Wilhelm M, Hamilton S; ATLANTIS Trials Investigators; ECASS Trials Investigators; NINDS rt-PA Study Group Investigators: Association of outcome with early stroke treatment: Pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 363:768-774, 2004.
14. Hacke W, Schwab S, Horn M, Spranger M, De Georgia M, von Kummer R: 'Malignant' middle cerebral artery territory infarction: Clinical course and prognostic signs. Arch Neurol 53:309-315, 1996.
15. IMS Study Investigators: Combined intravenous and intra-arterial recanalization for acute ischemic stroke: The Interventional Management of Stroke Study. Stroke 35:904-911, 2004.
16. IMS Study Investigators: Hemorrhage in the Interventional Management of Stroke study. Stroke 37:847-851, 2006.
17. Jansen O, von Kummer R, Forsting M, Hacke W, Sartor K: Thrombolytic therapy in acute occlusion of the intracranial internal carotid artery bifurcation. AJNR Am J Neuroradiol 16:1977-1986, 1995.
18. Kim D, Jahan R, Starkman S, Abolian A, Kidwell CS, Viñuela F, Duckwiler GR, Ovbiagele B, Vespa PM, Selco S, Rajajee V, Saver JL: Endovascular mechanical clot retrieval in a broad ischemic stroke cohort. AJNR Am J Neuroradiol 27:2048-2052, 2006.
19. Kim DJ, Kim DI, Byun JS, Jung JY, Suh SH, Kim EY, Lee KY, Heo JH: Simple microwire and microcatheter mechanical thrombolysis with adjuvant intraarterial urokinase for treatment of hyperacute ischemic stroke patients. Acta Radiol 49:351-357, 2008.
20. Levy EI, Ecker RD, Horowitz MB, Gupta R, Hanel RA, Sauvageau E, Jovin TG, Guterman LR, Hopkins LN: Stent-assisted intracranial recanalization for acute stroke: Early results. Neurosurgery 58:458-463, 2006.
21. Lewandowski CA, Frankel M, Tomsick TA, Broderick J, Frey J, Clark W, Starkman S, Grotta J, Spilker J, Khoury J, Brott T: Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial. Stroke 30:2598-2605, 1999.
22. Lloyd-Jones D, Adams R, Carnethon M, De Simone G, Ferguson TB, Flegal K, Ford E, Furie K, Go A, Greenlund K, Haase N, Hailpern S, Ho M, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott M, Meigs J, Mozaffarian D, Nichol G, O'Donnell C, Roger V, Rosamond W, Sacco R, Sorlie P, Stafford R, Steinberger J, Thom T, Wasserthiel-Smoller S, Wong N, Wylie-Rosett J, Hong Y; America Heart Association Statistics Committee and Stroke Statistics Subcommittee: Heart disease and stroke statistics-2009 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 119:e21-e181, 2009.
23. Mattle HP, Arnold M, Georgiadis D, Baumann C, Nedeltchev K, Benninger D, Remonda L, von Büdingen C, Diana A, Pangalu A, Schroth G, Baumgartner RW: Comparison of intraarterial and intravenous thrombolysis for ischemic stroke with hyperdense middle cerebral artery sign. Stroke 39:379-383, 2008.
24. Montavont A, Nighoghossian N, Derex L, Hermier M, Honnorat J, Philippeau F, Belo M, Turjman F, Adeleine P, Froment JC, Trouillas P: Intravenous r-TPA in vertebrobasilar acute infarcts. Neurology 62:1854-1856, 2004.
25. Nakajima M, Kimura K, Ogata T, Takada T, Uchino M, Minematsu K: Rela-tionships between angiographic findings and National Institutes of Health stroke scale score in cases of hyperacute carotid ischemic stroke. AJNR Am J Neuroradiol 25:238-241, 2004.
26. National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group: Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333:1581-1587, 1995.
27. Nedeltchev K, Fischer U, Arnold M, Ballinari P, Haefeli T, Kappeler L, Brek-Enfeld C, Remonda L, Schroth G, Mattle HP: Long-term effect of intra-arterial thrombolysis in stroke. Stroke 37:3002-3007, 2006.
28. Smith WS, Sung G, Saver J, Budzik R, Duckwiler G, Liebeskind DS, Lutsep HL, Rymer MM, Higashida RT, Starkman S, Gobin YP; Multi MERCI Investigators, Frei D, Grobelny T, Hellinger F, Huddle D, Kidwell C, Koroshetz W, Marks M, Nesbit G, Silverman IE: Mechanical thrombectomy for acute ischemic stroke: Final results of the Multi MERCI trial. Stroke 39:1205-1212, 2008.
29. Smith WS, Sung G, Starkman S, Saver JL, Kidwell CS, Gobin YP, Lutsep HL, Nesbit GM, Grobelny T, Rymer MM, Silverman IE, Higashida RT, Budzik RF, Marks MP; MERCI Trial Investigators: Safety and efficacy of mechanical embolectomy in acute ischemic stroke: Results of the MERCI trial. Stroke 36:1432-1438, 2005.
30. Szoeke CE, Parsons MW, Butcher KS, Baird TA, Mitchell PJ, Fox SE, Davis SM: Acute stroke thrombolysis with intravenous tissue plasminogen activator in an Australian tertiary hospital. Med J Aust 178:324-328, 2003.
31. Tomsick T, Brott T, Barsan W, Broderick J, Haley EC, Spilker J, Khoury J: Prognostic value of the hyperdense middle cerebral artery sign and stroke scale score before ultraearly thrombolytic therapy. AJNR Am J Neuroradiol 17:79-85, 1996.
32. Wolpert SM, Bruckmann H, Greenlee R, Wechsler L, Pessin MS, del Zoppo GJ: Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator. The rt-PA Acute Stroke Study Group. AJNR Am J Neuroradiol 14:3-13, 1993.
33. Yamaguchi T, Hayakawa T, Kiuchi H: Intravenous tissue plasminogen activator ameliorates the outcome of hyperacute embolic stroke. Cerebrovasc Dis 3:269-272, 1993.